Investigates physical confinement barriers affecting CAR T-cell migration in solid tumours, suggesting new immunotherapy strategies.
Chimeric Antigen Receptor (CAR) T-cell migration and infiltration into solid tumours remains a central challenge for cancer immunotherapy. While factors such as chemokine gradients, extracellular matrix (ECM) stiffness, and immunosuppressive...
No takes yet. Share an insight, caveat, or question.
Abrego et al. (2026) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: